HedgeChatter

ANI Pharmaceuticals Reports Record Net Revenues of $10.9 million, EPS of $0.33, and Adjusted Non-GAAP EBITDA of $4.2 Million for the First Quarter Ended March 31, 2014

05 May

ANI Pharmaceuticals Reports Record Net Revenues of $10.9 million, EPS of $0.33, and Adjusted Non-GAAP EBITDA of $4.2 Million for the First Quarter Ended March 31, 2014

Bystocknews , Comments Off on ANI Pharmaceuticals Reports Record Net Revenues of $10.9 million, EPS of $0.33, and Adjusted Non-GAAP EBITDA of $4.2 Million for the First Quarter Ended March 31, 2014

[PR Newswire] – BAUDETTE, Minn., May 5, 2014 /PRNewswire/ — ANI Pharmaceuticals, Inc. (ANI) (NASDAQ: ANIP) today reported financial results for the three months ended March 31, 2014. First quarter highlights … more

View todays social media effects on ANIP

View the latest stocks trending across Twitter. Click to view dashboard

See who ANI is hiring next, click here to view

Share this post

Author

stocknews